Italy Diabetes Care Devices Market Share, Trends, Revenue, Demand, Growth Drivers, Challenges, Key Players, and Future Investment Opportunities Till 2033


Italy Diabetes Care Devices Market Share, Trends, Revenue, Demand, Growth Drivers, Challenges, Key Players, and Future Investment Opportunities Till 2033: SPER Market Research

 Category : Medical Devices

 Published: Jun-2024
 Author: SPER Analyst

Italy Diabetes Drugs and Devices Market is projected to be worth USD 1.85 billion by 2033 and is anticipated to surge at a CAGR of 6.31%.

Diabetes mellitus, a chronic metabolic disease marked by increased blood sugar levels, is managed and treated with a wide range of medications and medical devices known as diabetes drugs and devices. The pharmaceutical component comprises blood glucose-regulating injectable treatments, insulin, and oral hypoglycemic medicines. One possible way that these medications function is by either increasing insulin sensitivity, promoting insulin synthesis, or preventing the liver from producing glucose. Conversely, diabetes gadgets are made up of different instruments meant to measure blood sugar, give insulin, and treat the condition efficiently. In order to improve diabetes care and patient outcomes, this comprises glucose meters for self-monitoring, continuous glucose monitoring (CGM) devices, insulin pumps, insulin pens, and other cutting-edge technologies.

Italy Diabetes Drugs and Devices Market Driving Factors and Challenges

Drivers: In recent years, the prevalence of diabetes has alarmingly increased in Italy. In order to maintain normal blood glucose levels, patients with diabetes need to make numerous adjustments throughout the day. These adjustments could include taking anti-diabetic medication or eating more carbs while keeping an eye on their blood glucose levels. Obesity, poor diet, and physical inactivity are the main causes of the rising rate of newly diagnosed Type 1 and Type 2 diabetes patients. Diabetes medication use is rising, as seen by the quickly rising incidence, prevalence, and healthcare costs of diabetes individuals. 

Furthermore, Continuous glucose monitoring devices, also referred to as automated glucose monitoring systems, consist of a small device that can be worn on the body and is attached to it by an adhesive patch. The sensor part of the device uses samples of interstitial fluid obtained through an epidermal cannula to monitor glucose levels.

Challenges: The cost that diabetes and its complications place on the healthcare system financially is a major challenge. As with many other countries, Italy faces growing expenses for managing diabetes, including drugs and devices, in addition to the growing costs of treating diabetes-related complications including neuropathy and cardiovascular disorders. In addition, payment policies and regulatory obstacles could prevent patients from accessing cutting-edge care and delay the adoption of innovative diabetes treatments and technologies.

Impact of COVID-19 on Italy Diabetes Drugs and Devices Market
Italy's COVID-19 pandemic has had a significant negative impact on diabetic care devices. Opportunities for developing and expanding diabetes care delivery were highlighted by the pandemic. These included the utilization of diabetes technologies and online consultations between diabetics and medical experts. Many long-standing regulatory constraints have been lifted thanks to crisis management, and patients and physicians are now demanding remote care at a level never seen before. As a result, the COVID-19 epidemic hastened the industry's growth in diabetes care devices.

Italy Diabetes Drugs and Devices Market Key Players:
The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players are; Abbott Diabetes Care, Arkray Inc., Ascensia Diabetes Care, Dexcom, Insulet Corporation, Eli Lilly, LifeScan Inc., Medtronic, Novo Nordisk A/S, Roche Diabetes Care, Rossmax International Ltd., Sanofi.

Italy Diabetes Drugs and Devices Market Segmentation:

By Management Devices: Based on the Management Devices, Italy Diabetes Drugs and Devices Market is segmented as; Insulin Pump, Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, Jet Injectors.

By Monitoring Devices: Based on the Monitoring Devices, Italy Diabetes Drugs and Devices Market is segmented as; Self-Monitoring Devices, Continuous Glucose Monitoring.

By Region: This research also includes data for Eastern Region, Western Region, Southern Region, Northern Region.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Johnson & Johnson


Market Research

We are the leading, full-service global market research and consulting company.

iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]